ArticleClinical case reports2021

New-generation anticancer drugs and medication-related osteonecrosis of the jaw (MRONJ): Late onset 3 years after ipilimumab endovenous administration with a possible role of target therapy.

Agostino Guida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.